key: cord-0953911-iq8606qb authors: Kanamori, Hajime title: An overview of research on air and environmental contamination with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings date: 2020-12-10 journal: Infection control and hospital epidemiology DOI: 10.1017/ice.2020.1366 sha: 71b09baedb91ac6c18c56518d004b78f23c99771 doc_id: 953911 cord_uid: iq8606qb nan Studies of air and environmental surfaces found that if air samples were positive for SARS-CoV-2 RNA, environmental surface samples were also (Table 1) . 2, 3, 5, 8, 9, 11 Air samples taken <1 m from a patient receiving high-flow nasal cannula oxygen therapy were contaminated, but air and surface contamination levels were lower in intensive care units probably because of the use of closed-circuit ventilation systems. 11 Several studies have shown that even when air samples were negative for SARS-CoV-2 RNA, environmental samples from air outlets were positive. 1,7, 10 Wei et al 10 reported that surfaces in patient rooms with air exhaust outlets that tested positive for SARS-CoV-2 RNA were frequently contaminated (26.7%-95.7%), suggesting that small virus-laden particles are present around patients. In one study, environmental samples collected after cleaning and disinfection, and all air samples except for those from air exhaust outlets, were negative in RT-PCR, although the small volumes of the samples may have affected these results. 7 Person-to-person SARS-CoV-2 transmission occurs primarily via respiratory droplets and contact, but some scientists suggested that airborne transmission (microdroplets or aerosols) also occurs. 14 Several studies have shown that air samples were positive for SARS-CoV-2 RNA in isolation rooms with 12 air changes per hour. 2,3,9 Viral RNA was detected in the air within 4 m of a patient, indicating possible aerosol transmission of SARS-CoV-2. 3 Samples from the air around severely ill patients treated with aerosolgenerating procedures were likely to be positive for SARS-CoV-2 RNA. 5, 8, 11 However, the positivity rates of air samples collected around patients who did not receive aerosol-generating procedures have been discordant, 1,2,7,9,10 while environmental surface samples were positive for SARS-CoV-2 RNA in all of these studies. Tang et al 15 also reviewed the scientific evidence for aerosol transmission of SARS-CoV-2 and potential control measures in various situations and populations, highlighting that healthcare personnel are at high risk for aerosol transmission of SARS-CoV-2 in the closed hospital environment. 15 Viral aerosol particles can be generated by mildly ill patients without a cough, leading to extensive environmental and potential aerosol contamination with SARS-CoV-2; however, no cases of COVID-19 were documented in healthcare personnel who took airborne precautions. 9 On this basis, healthcare personnel should implement airborne precautions when performing aerosol-generating procedures in patients with COVID-19. Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19) Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards Do established infection prevention and control measures prevent spread of SARS-CoV-2 to the hospital environment beyond the patient room? SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care Asymptomatic COVID-19 patients can contaminate their surroundings: an environment sampling study Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London Role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation It is time to address airborne transmission of COVID-19 Aerosol transmission of SARS-CoV-2? Evidence, prevention and control Acknowledgments.Financial support. No financial support was provided relevant to this article. All author reports no conflicts of interest relevant to this article.